Acute ischemic stroke caused by proximal intracranial arterial occlusion continues to challenge acute stroke care protocols worldwide. Clinicians frequently encounter patients presenting with a low-NIHSS LVO stroke, where mild baseline neurological deficits mask a massive underlying vascular obstruction. While mechanical thrombectomy offers definitive reperfusion for severe presentations, clinical management remains highly controversial when the initial National Institutes of Health Stroke Scale score is low. Recent systematic evidence highlights the indispensable role of advanced perfusion imaging in identifying vulnerable penumbral tissue and predicting early neurological deterioration.

The Clinical Dilemma of Low-NIHSS LVO Stroke Presentations

Patients presenting with minor or non-disabling deficits despite a major proximal occlusion create a profound therapeutic dilemma in the emergency department. Consequently, clinicians must balance the potential hazards of procedural intervention against the high risk of sudden clinical worsening. The baseline NIHSS often underrepresents deficits arising from right-hemisphere syndromes, isolated aphasia, or distal branch territories. Therefore, relying solely on clinical examination scores may create false reassurance during triage. Collateral circulation might temporarily sustain oxygenation in the territory distal to the arterial obstruction. However, collateral flow remains intrinsically fragile and sensitive to acute blood pressure fluctuations. If these compensatory collateral channels suddenly fail or thrombi propagate distally, patients frequently experience rapid functional decline. Furthermore, standard medical management alone may prove insufficient to protect critically threatened brain tissue over subsequent hours. Historically, landmark thrombectomy trials systematically excluded individuals with mild baseline presentations. As a result, interventional stroke teams have lacked high-level randomized evidence to guide immediate revascularization strategies in this specific population. Advanced neuroimaging now bridges this diagnostic gap by uncovering ischemic vulnerability that standard bedside physical examinations consistently miss.

Perfusion Imaging Biomarkers and Risk Stratification

Advanced computed tomography perfusion and magnetic resonance perfusion offer deep physiological insights into cerebral hemodynamics. Specifically, automated perfusion software measures time-to-maximum delay and relative cerebral blood flow to delineate irreversible ischemic core from salvageable penumbra. In a low-NIHSS LVO stroke, a critically prolonged Tmax exceeding six seconds over a sizable territory signals substantial tissue at risk. Additionally, impaired hemodynamic reserve and delay in mean transit time reflect severely exhausted collateral support. Systematic reviews demonstrate that patients exhibiting large perfusion mismatch volumes face significantly higher rates of early neurological deterioration. When penumbral tissue remains poorly perfused, even minor physiological stressors can convert viable neurons into infarcted tissue. Therefore, quantitative volumetric thresholds provide vital objective biomarkers of physiological instability. Clinicians can utilize these perfusion metrics to detect latent hemodynamic failure hours before neurological deterioration becomes clinically manifest. Incorporating automated quantitative maps into emergency protocols standardizes risk assessment across acute stroke units.

Meta-Analytic Insights on Deterioration and Functional Outcomes

Recent meta-analytic evidence confirms the formidable prognostic value of advanced perfusion imaging in minor acute ischemic stroke. In pooled analyses, a high-risk perfusion phenotype correlated with a more than sixfold increase in the odds of early neurological deterioration. Similarly, patients presenting with extensive hypoperfusion volumes exhibited a ninefold increase in poor three-month functional outcomes compared to those with preserved tissue perfusion. These robust statistical associations underscore that ischemic tissue vulnerability, rather than initial bedside symptom severity, governs long-term patient recovery. Consequently, perfusion imaging serves as a powerful predictive instrument for risk stratification in acute emergency triage. Nevertheless, observational studies exhibit moderate-to-high heterogeneity, reflecting variations in post-processing algorithms, time windows, and collateral evaluation methods. In addition, retrospective cohort designs may inadvertently introduce selection bias into reported treatment effects. Despite these methodological limitations, the quantitative data consistently confirm that large perfusion defects indicate impending clinical worsening that clinicians cannot ignore.

Endovascular Decision-Making: Current Evidence and Controversies

Although perfusion imaging accurately identifies patients at high risk of neurological decline, establishing its definitive role as a trigger for immediate thrombectomy remains challenging. Current evidence evaluating perfusion-guided endovascular intervention in minor stroke relies predominantly on observational cohorts and non-randomized registries. Consequently, whether urgent mechanical thrombectomy improves disability-free survival compared to best medical therapy with rescue intervention remains uncertain. Interventional procedures inherently carry procedural risks, including vessel perforation, distal embolization, and reperfusion hemorrhage. Therefore, clinicians must carefully weigh procedural hazards against the probability of spontaneous collateral preservation or thrombus lysis. Ongoing randomized controlled trials, such as MILD-MT and MOSTE, specifically investigate whether imaging-selected mechanical intervention outperforms medical therapy in low-NIHSS presentations. Until definitive randomized data emerge, multimodal imaging parameters should inform individual multidisciplinary case discussions rather than serve as rigid, universal indications for intervention. Careful clinical synthesis remains paramount.

Practical Clinical Workflow for Emergency Management

Emergency stroke pathways must adopt standardized protocols to evaluate patients with acute mild deficits suspected of harboring large-vessel occlusions. First, clinicians should obtain urgent non-contrast computed tomography alongside CT angiography from the aortic arch to the vertex. If angiography confirms a proximal occlusion, immediate computed tomography perfusion should quantify ischemic core and hypoperfused tissue volume. Second, teams must evaluate individual patient factors, including baseline functionality, symptom onset latency, and intravenous thrombolysis eligibility. Patients demonstrating extensive mismatch with minimal core injury require continuous, high-dependency neurological monitoring. If hemodynamic reserve appears severely compromised, interventional and neurological teams should conduct rapid multidisciplinary consultations regarding catheter angiography. Furthermore, strict blood pressure parameters must prevent collateral collapse during acute stabilization. By integrating advanced physiological imaging with meticulous bedside monitoring, clinicians can promptly detect clinical decline and deploy rescue strategies without unnecessary procedural delays.

Frequently Asked Questions

Why is NIHSS alone insufficient for assessing large-vessel occlusion?

The NIHSS prioritizes motor weakness and language deficits while underrepresenting non-dominant cortical signs, visual field defects, and distal ischemia. Furthermore, strong collateral circulation can temporarily mask underlying ischemia during early examination. Consequently, patients with mild scores may still harbor extensive threatened penumbra vulnerable to sudden hemodynamic failure and clinical worsening.

How does perfusion imaging define tissue at risk in mild stroke?

Perfusion imaging measures transit delays and blood flow metrics to differentiate infarcted core from hypoperfused tissue. A time-to-maximum delay exceeding six seconds across sizable brain volumes indicates critical hypoperfusion. This volumetric mismatch identifies viable but threatened parenchyma that remains dependent on tenuous collateral pathways for ongoing cellular survival.

Should all low-NIHSS patients with large-vessel occlusions undergo thrombectomy?

Current clinical evidence does not support universal thrombectomy for all minor strokes with large-vessel occlusions. While perfusion imaging identifies high-risk individuals, randomized trials evaluating endovascular safety and efficacy in this cohort remain ongoing. Clinicians must personalize treatment decisions through multidisciplinary evaluation, balancing procedural risks against individual patient characteristics.

Disclaimer: This content is for informational and educational purposes only. It is not intended to substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified healthcare provider with any questions you may have regarding a medical condition or treatment options. Never disregard professional medical advice or delay in seeking it because of something you have read here. Clinical judgment must guide all medical decisions. Refer to the latest local and national guidelines for clinical practice.

References

1. Liu C et al. Perfusion imaging-guided risk stratification and endovascular decision-making in low-NIHSS large-vessel occlusion stroke: a systematic review and exploratory meta-analysis. J Neurol. 2026 Aug 26. doi: 10.1007/s00415-026-14075-7. PMID: 42645435.
2. Seners P, Turc G, Oppenheim C, et al. Incidence, causes and predictors of neurological deterioration occurring within 24 h following acute ischemic stroke: a systematic review. J Neurol Neurosurg Psychiatry. 2015;86(1):87-94.
3. Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med. 2018;378(8):708-718.